DAMIAN BROUSSARD: Open Payments
NPI 1154660124 · JENNINGS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 136 payments from 17 companies in 2025. Trend: 2023 $1,668 · 2024 $1,953 · 2025 $2,514
Food & beverage: $2,329Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $496 |
| GENZYME CORPORATION | 15 | $408 |
| PFIZER INC. | 22 | $303 |
| ABBVIE INC. | 22 | $286 |
| Galderma Laboratories, L.P. | 15 | $212 |
| UCB, Inc. | 9 | $185 |
| Organon LLC | 11 | $173 |
| Incyte Corporation | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $68 |
Products named: TREMFYA, DUPIXENT, CIBINQO, NEMLUVIO, SKYRIZI, Bimzelx, OPZELURA, RINVOQ.
Industry payments across LA — which companies pay providers there.
